Adjunctive medical therapies for acute stroke thrombolysis: is there a CLEAR-ER choice?

Stroke. 2013 Sep;44(9):2377-9. doi: 10.1161/STROKEAHA.113.001830. Epub 2013 Jul 25.
No abstract available

Keywords: Bayes theorem; platelet glycoprotein GPIIb-IIIa complex; stroke; thrombolytic therapy.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Brain Ischemia / drug therapy*
  • Eptifibatide
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Intracranial Hemorrhages / chemically induced*
  • Male
  • Peptides / adverse effects*
  • Platelet Aggregation Inhibitors / adverse effects*
  • Stroke / drug therapy*
  • Thrombolytic Therapy / adverse effects*
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Fibrinolytic Agents
  • Peptides
  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator
  • Eptifibatide